Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer
Casey R. Ager, Aleksandar Obradovic, Patrick McCann, Matthew Chaimowitz, Alexander L. E. Wang, Neha Shaikh, Parin Shah, Samuel S. Pan, Caroline J. Laplaca, Renu K. Virk, Jessica C. Hill, Collin Jugler, Grace DeFranco, Nilika Bhattacharya, Kade R. Copple, Howard I. Scher, Guarionex Joel DeCastro, Christopher B. Anderson, James M. McKiernan, Catherine S. Spina, Mark N. Stein, Karie Runcie, Charles G. Drake, Andrea Califano, Matthew C. Dallos
medRxiv 2024.09.09.24313308; doi: https://doi.org/10.1101/2024.09.09.24313308